Found: 9
Select item for more details and to access through your institution.
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 11, p. 1, doi. 10.1038/s41419-023-06233-w
- By:
- Publication type:
- Article
The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, p. 1, doi. 10.1186/s40164-024-00484-9
- By:
- Publication type:
- Article
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 2, p. 172, doi. 10.1002/cpdd.645
- By:
- Publication type:
- Article
Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01257-9
- By:
- Publication type:
- Article
The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22872-z
- By:
- Publication type:
- Article
Assessment of Treatment Effect With Multiple Outcomes in 2 Clinical Trials of Patients With Duchenne Muscular Dystrophy.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 2, p. e1921306, doi. 10.1001/jamanetworkopen.2019.21306
- By:
- Publication type:
- Article
Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article